Qiagen NV (QGEN) Stock: Evaluating the Market Performance
The price-to-earnings ratio for Qiagen NV (NYSE: QGEN) is 102.92x, which is above its average ratio. Moreover, the 36-month beta value for QGEN is 0.65.
The price-to-earnings ratio for Qiagen NV (NYSE: QGEN) is 102.92x, which is above its average ratio. Moreover, the 36-month beta value for QGEN is 0.65.
The stock price of Novartis AG ADR (NYSE: NVS) has surged by 1.02 when compared to previous closing price of 112.28, but the company has
The stock of Weave Communications Inc (WEAV) has gone down by -7.91% for the week, with a 11.91% rise in the past month and a
DINO has 36-month beta value of 0.87. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 6 as “overweight,”
NextDecade Corporation (NASDAQ: NEXT) has experienced a decline in its stock price by -2.37 compared to its previous closing price of 7.38. However, the company
In the past week, FUTU stock has gone down by -1.90%, with a monthly gain of 28.42% and a quarterly plunge of -9.12%. The volatility
Constellation Energy Corporation (NASDAQ: CEG) has a higher price-to-earnings ratio of 30.64x compared to its average ratio, The 36-month beta value for CEG is at
Chagee Holdings Ltd. ADR (NASDAQ: CHA) has seen a rise in its stock price by 4.60 in relation to its previous close of 29.16. However,
The stock of ING Groep N.V. ADR (ING) has seen a 2.88% increase in the past week, with a 13.42% gain in the past month,
Additionally, the 36-month beta value for JMIA is 2.85. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0
© 2024, Powered by Smart TechOne